Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06663384 · ClinicalTrials.gov registry record · NA

ARVIS TKA vs Conventional TKA

A NA study of Osteoarthritis, sponsored by Foundation for Orthopaedic Research and Education.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06663384 is a NA study of Osteoarthritis that is actively recruiting participants, run by Foundation for Orthopaedic Research and Education. The registered enrollment target is 50 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06663384, a NA study of Osteoarthritis, is actively recruiting participants, sponsored by Foundation for Orthopaedic Research and Education.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study is a pilot analysis of a novel augmented reality guidance platform, the augmented reality visualization and information system (ARVIS, Insight Medical), with aims to demonstrate accuracy of bone resection and implant alignment during kinematic alignment total knee arthroplasty.

Conditions Studied

Interventions

  • OTHER Evaluation of Augmented Reality technology in TKA compared to standard TKA

Study Locations (1)

Florida

  • Florida Orthopaedic Institute - Tampa

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-12-01
Est. Completion 2027-11-01
Phase NA

What the Registry Record Tells You About NCT06663384

The ClinicalTrials.gov registry entry for NCT06663384 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (94% lower). The listed sponsor is Foundation for Orthopaedic Research and Education, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Evaluation of Augmented Reality technology in TKA compared to standard TKA is the first listed.

NCT06663384 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06663384 about?

NCT06663384 is a clinical study titled "ARVIS TKA vs Conventional TKA". This study is a pilot analysis of a novel augmented reality guidance platform, the augmented reality visualization and information system (ARVIS, Insight Medical), with aims to demonstrate accuracy of bone resection and implant alignment during kinematic alignment total knee arthroplasty.

What is the current status of trial NCT06663384?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-12-01. Estimated completion is 2027-11-01.

What conditions does trial NCT06663384 study?

This clinical trial studies the following conditions: Osteoarthritis.

What interventions are being tested in trial NCT06663384?

The interventions under investigation include: Evaluation of Augmented Reality technology in TKA compared to standard TKA (OTHER).

Who is sponsoring clinical trial NCT06663384?

This trial is sponsored by Foundation for Orthopaedic Research and Education, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06663384 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.